cell therapy treatment
success of cell
available cell-based treatments
longitudinal stem cell tracking
nTRACK nanoparticles
functional tracking of stem cell therapy
muscle regeneration Cell therapy
nTRACK technology
main goal of nTRACK
stem cells
early biodistribution
predictive model
personalised treatment
treatment efficacy
synthesis of nTRACK NPs
Multimodal nanoparticles
early assessment of treatment effectiveness
biodistribution patterns
body biodistribution
viability
real-time tracking of transplanted cells
imaging infrastructure
non-clinical safety studies
clinical trials
muscular injury sheep model
imaging modalities
disease symptoms
sensitive multimodal nanoimaging agent
knowledge
promising opportunities
size fits
regulatory authorities
typical migration
short-term evaluation
series of formal interactions
PET
prompt introduction
current lack of methods
cellular labeling processes
combination of CT
good manufacturing practice
GMP
requirements
diseases
end
conclusions
MRI
concept
addition
overall management
earlier stages
major weakness
information
progression
hospital settings
effective therapies
project
prognosis
need of tools